Oncology-Monoclonal Antibodies Flashcards
Avastin
Bevacizumab
VEGF inhibitors
Mvasi
Bevacizumab-awwb
VEGF inhibitors
Cyramza
Ramucirumab
VEGF inhibitors
Erbitux
Cetuximab
EGFR inhibitors
Vectibix
Panitumumab
EGFR inhibitors
Herceptin
Trastuzumab
HER2 Inhibitors
Ogivri
Trastuzumab dkst
HER2 Inhibitors
Kadcyla
Ado-trastuzumab emtansine
Trastuzumab conjugated to a microtubule inhibitor
HER2 Inhibitors
Rituxan
Rituximab
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Arzerra
Ofatumumab
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Gazyva
Obinutuzumab
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Adcetris
Brentuximab vedotin
Conjugate to MMAE, a microtubule inhibitor
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Blyncyto
Blinatumomab
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Darzalex
Daratumumab
Bind to antigen expressed on specific hematopoietic cells and cause cell death, used to treat certain hematologic malignancies
Keytruda
Pembrolizumab
Programmed Death Receptor 1 (PD-1) inhibitors that increase immune system reaction against cancer cells